Allied Market Research


Chloramphenicol Eye Drops Market

Chloramphenicol Eye Drops Market Size, Share, Competitive Landscape and Trend Analysis Report by Type and by Application : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Pharmaceuticals

Select an option
Author's: | Roshan Deshmukh
Publish Date:

Get Sample to Email

Chloramphenicol eye drops are used to treat eye infections caused by bacteria (called bacterial conjunctivitis). Conjunctivitis is inflammation of the conjunctiva of the eye. The conjunctiva is a semi-transparent membrane that lines the inside of the eyelids and covers the white part of the eye (sclera). When the conjunctiva is inflamed, the white part of the eye appears red. Furthermore, most common symptoms are red eye and sticky eye (eyes are glued together especially in the morning on waking). Chloramphenicol is an antibiotic that works by preventing the growth of bacteria. In addition, chloramphenicol is given intravenously (directly into a vein) or as capsules. This is a treatment for serious infections that are almost often given in hospitals.

COVID-19 Impact Analysis

  • COVID-19 is an infectious disease that originated in Hubei province of the Wuhan city in China in late December. The highly contagious disease, caused by a virus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is transmitted from human to human. Since the outbreak in December 2019, the disease has spread to almost 213 countries around the globe with the World Health Organization declaring it a public health emergency on March 11, 2020.
  • Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicine supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are facing shortage of these drugs. Thus, the pharmaceutical and biotechnology industries are expected to witness a significant growth in the future, owing to the demand for vaccine and treatment drugs for COVID-19. This, in turn, is expected to have a significant impact on the global chloramphenicol eye drops market. 

Top Impacting Factors
Increase in prevalence of ophthalmic disorders and increase in geriatric population who are more prone to suffer from these eye disorders are expected to drive the growth of the  chloramphenicol eye drops market.
In addition, rise in awareness regarding the importance of eye care helps boost the market growth.
Furthermore, easy availability and accessibility of lubricating eye drops and drug discovery & development in eye care products fuel the market growth. 
In addition, surge in prevalence of dry eye syndrome across the world is expected to propel the market growth of chloramphenicol eye drops market.
However, side effects associated with ophthalmic eye drops are expected to hamper the chloramphenicol eye drops market growth.

Market Trends
New Product Launches to Flourish the Market

  • In July 2019, Novartis announced that it has completed its acquisition of Xiidra (lifitegrast ophthalmic solution) 5%, the first and only prescription treatment approved to treat both signs and symptoms of dry eye by inhibiting inflammation.
  • In September 2020, Dr. Reddy's Laboratories launched an over-the-counter (OTC) eye allergy drop Olopatadine Hydrochloride Ophthalmic Solution. It is indicated for the temporary relief of red eyes. 

Key Benefits of the Report

  • This study presents the analytical depiction of the chloramphenicol eye drops market industry along with the current trends and future estimations to determine the imminent investment pockets.
  • The report presents information related to key drivers, restraints, and opportunities along with detailed analysis of the chloramphenicol eye drops market share.
  • The current market is quantitatively analyzed to highlight the chloramphenicol eye drops market growth scenario.
  • Porter’s five forces analysis illustrates the potency of buyers & suppliers in the market. 
  • The report provides a detailed market analysis depending on competitive intensity and how the competition will take shape in coming years.

Questions Answered in the Chloramphenicol Eye Drops Market Report

  • Which are the leading market players active in the chloramphenicol eye drops market?
  • What are the current trends that will influence the market in the next few years?
  • What are the driving factors, restraints, and opportunities of the market?
  • What future projections would help in taking further strategic steps?
  • What is chloramphenicol eye drops market?
  • What is chloramphenicol eye drops market prediction in the future?
  • Who are the leading global players in the chloramphenicol eye drops market?
  • What are the current trends and predicted trends?
  • What are the key benefits of the chloramphenicol eye drops market report?

Chloramphenicol Eye Drops Market Report Highlights

Aspects Details
By Type
  • 0.5% Purity
  • 1% Purity
By Application
  • Online Retail
  • Offline Retail
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (Germany, France, UK, Italy, Spain, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)
Key Market Players

Ciron Drugs, Jawa Pharmaceuticals, Bausch & Lomb, Syntho Pharmaceuticals Private, Famar, Ethypharm, Aurolab, Ji’nan Aimin Pharmaceutical

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Chloramphenicol Eye Drops Market

Global Opportunity Analysis and Industry Forecast, 2023-2032